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Abstract
Objectives: To present our experience in managing encrusted ureteral stents and to review the literature on
the subject.
Methods: A total of 22 patients with encrusted ureteral stent were treated in our department. Encrustation of
the stent and associated stone burden were evaluated using plain radiography, sometimes supplemented by
intravenous urography or ultrasonography. The treatment method was determined by the site of encrustation,
the size of the stone burden and the availability of endourologic equipment.
Results: Stents were inserted for stone disease in 17 patients, for congenital abnormality in 3 and for ureteric
obstruction by malignancy in 2. Stents were left in place for a mean of 10.8 months (range 5–34 months).
The site of encrustation was in the bladder in 15 (68.2%), ureter in 13 (59%) and kidney in 8 patients
(36.4%); more than one site was involved in 11 (50%) cases. For upper coil encrustations, retrograde
ureterorenoscopy was performed in 9 cases, percutaneous nephrolithotomy in 4 and open pyelolithotomy in
2. For lower coil encrustation, fragmentation by grasper and/or transurethral cystolithotripsy was attempted
in 11 cases, and suprapubic cystolithotomy was required for failure in 7 cases. Sixteen patients (72.7%)
were rendered stone-free and 5 (22.7%) had clinically insignificant residual stones (3 mm or less).
Conclusions: Encrustation is one of the most difficult complications of ureteral stents and its management is
a complex clinical scenario for the treating surgeon. The combination of several surgical techniques is often
necessary but the best treatment remains the prevention of this problem by providing patient education.
© 2012 Production and hosting by Elsevier B.V. on behalf of Pan African Urological Surgeons’ Association.
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was performed in 9 cases, PCNL in 4 and open pyelolithotomy in 2.
A single anesthetic session was required in 18 patients (81.8%) and
a second session was necessary in 4 patients due to breakage of the
stent at the first attempt at removal. No intraoperative complications32
ntroduction
reteral stents have become a fundamental part of urological
ractice. They are chiefly used for managing ureteral obstruction
ue to intrinsic or extrinsic causes (stones, tumours, and fibrosis) and
or providing drainage after ureteral surgery or iatrogenic injuries.
owever, some problems related to their use still occur despite the
mprovements in materials and design. A well-known complication
f this situation is stent encrustation, which can result in signifi-
ant morbidity such as stone formation, recurrent obstruction and
rinary tract infection (UTI). Various procedures can be used for
he retrieval of encrusted stents. We present our experience with the
anagement of this complication.
ubjects and methods
wenty-two patients (18 men and 4 women) were admitted to our
epartment with a retained encrusted ureteral stent between January
002 and October 2011. Information was obtained through a retro-
pective study of the patients’ records. A retained ureteral stent was
efined as one that could not be removed at the first attempt using
entle manual traction with grasping forceps passed through a cys-
oscope under local anesthesia. All the patients were thoroughly
valuated for stent encrustation and stone burden by plain-film
adiography, sometimes supplemented by intravenous urography (6
ases) or ultrasonography (5 cases). Serum creatinine measurement
nd urinalysis with culture were also performed to evaluate renal
unction and to detect UTI. Retrograde ureteroscopy using a 7.5F
igid ureteroscope and intra-corporeal lithotripsy with a pneumatic
ithotripter were used as initial treatment for encrustation involving
he stent body. The ureteroscope was advanced beside the retained
tent and lithotripsy was used to fragment encrustations on and
round the stent (Fig. 1). Thereafter, an attempt was made to retrieve
he stent with the help of a ureteroscopic grasper. If this technique
ailed, if encrustations involved the upper coil of the stent, percu-
aneous nephrolithotomy (PCNL) using a rigid 24F nephroscope
r open nephrolithotomy was performed. If encrustations involved
he lower coil of the stent, fragmentation was performed using a
igid grasper or transurethral cystolithotripsy. If the endovesical
igure 1 Fluoroscopic image showing the ureteroscope beside the
etained ureteral stent.
F
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ptions failed, open surgery was performed to remove the stone
nd the encrusted stent. Postoperatively, plain-film radiography was
btained to confirm the stone-free and stent-free status.
esults
he mean patient age was 33.4 years (range 7–64 years). Stents
ere left in place for a mean of 10.8 months (range 5–34 months),
stents (22.7%) were indwelling for 5–6 months and 5 (22.7%)
ere indwelling for ≥12 months. Seventeen patients (77.3%) had
equired stenting due to obstruction caused by stone disease. In two
ases, the stent had been placed to prevent obstruction by malig-
ancy (uterine choriocarcinoma and cervical cancer). The stent was
nserted after endopyelotomy for pelvi-ureteric junction obstruc-
ion, after surgery for megaureter and after surgery for a retroiliac
reter in one case each. Encrustations were radiopaque in 20 cases
90.1%). Renal function was preserved in all cases. UTI was found
n 10 cases (45.5%). Encrustations were localized to the stent coils
nd/or throughout the length of the stent body (Figs. 2 and 3). The
ite of encrustation was in the bladder in 15 (68.2%), ureter in 13
59%) and kidney in 8 patients (36.4%); more than one site was
nvolved in 11 (50%) cases. Extracorporeal shock-wave lithotripsy
ESWL) was used unsuccessfully in three patients (13.6%) before
eferral to our department. For lower coil encrustation, fragmenta-
ion by grasper and/or transurethral cystolithotripsy was attempted
n 11 cases, and suprapubic cystolithotomy was required for failure
n 7 cases. For upper coil encrustations, retrograde ureterorenoscopyigure 2 Plain-film radiograph showing encrusted ureteral stent with
arge stone burden in bladder, kidney and ureter.
Encrusted ureteral stents
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aFigure 3 Plain-film radiograph showing encrusted ureteral stent with
large stone burden in bladder, kidney and lower part of ureter.
occurred in any patient. All the stents were removed intact, except
in 4 patients (Fig. 4). Examination of the broken stents showed that
breaks had occurred at points where the encrustation had made the
stent very brittle. All the removed encrusted stents were made of
silicone. Sixteen patients (72.7%) were rendered stone-free and 5
(22.7%) had clinically insignificant residual stones (3 mm or less).
The mean hospital stay was 3.8 days (range 1–9 days).
Figure 4 Examples of removed ureteral stents.
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iscussion
ncrustation of forgotten ureteral stents is a serious problem, espe-
ially when a large stone burden has developed. The main causes
f this complication are poor patient compliance with instructions
o return for stent removal, and inadequate counsel by practition-
rs. The exact mechanism of encrustation is not clear. However, it
ppears to be dependent on several factors [1–6]. UTI is one of these
actors. Urease produced by bacteria hydrolyses urea in the urine to
roduce ammonia causing elevated urinary pH and favoring the pre-
ipitation of magnesium and calcium as struvite and hydroxyapatite
nto the stent surface [5,7]. Duration of placement is another factor:
arious authors have reported that indwelling time between 2 and 4
onths is safe [8–12]. Patients requiring stents beyond this period
hould be kept on prophylactic antibiotics and have their stents fre-
uently changed. Stent material may contribute to encrustation:
ilicone containing stents tend to be more resistant to encrusta-
ion, followed by polyurethane, silitek, percuflex and hydrogel
oated polyurethane [13]. Other factors include urinary composi-
ion (hypercalciuria, hyperoxaluria, hypocitraturia, homocystinuria,
nd hyperuricosuria), a history of urolithiasis, and congenital uri-
ary tract anomalies. Malignancy predisposes to stent encrustation,
ossibly due to urinary stasis induced by dehydration and poor
uid intake, chemotherapy-induced hyperuricosuria, persistent or
ecurrent UTI, multiple serial stents, and poor compliance [14].
tent breakage is sometimes associated with encrustation in forgot-
en stents. Stents may fracture spontaneously after being in situ for
long time, due to hardening and loss of tensile strength [15].
ost studies showed a predominance of encrustation at the upper
oil of the stent. This may be because more effective peristalsis at
he lower part of the stent sweeps any deposits off the stent, thus
inimizing encrustation at the lower end [6,14]. In this study, stent
ncrustation was more common in the bladder (68.2%) and ureter
59%) than in the kidney (36.4%), possibly because urine remains
n the bladder for a longer time than in the upper urinary tract.
he management of ureteral stents with encrustation remains a chal-
enging task for urologists. The site of encrustation, the size of the
tone burden and the function of the affected kidney dictate the
ethod of treatment. Very often, multiple approaches are needed
ecause of encrustations involving the bladder, ureter and kidney
4,8,11,14–17].
or encrustations located at the upper coil and/or stent body, ESWL
as been reported to be a non-invasive and effective first line therapy
10,11,18,19]. The shock waves can be directed at the proximal or
reteral part of the encrusted stent under fluoroscopic guidance.
SWL is indicated mainly for localized, low volume encrustations
20,21].
reteroscopy using pneumatic or ultrasonic lithotripsy may also
e attempted, either as first-line therapy or after failure of ESWL
9,14,22,23]. Flexible ureteroscopy with holmium laser lithotripsy
s an alternative minimally invasive treatment option [19,22,24,25].
ore invasive procedures, such as PCNL or open pyelolithotomy
re often necessary for treating a severely encrusted stent [11,15].
ncrustations located at the lower coil are generally managed by
ndovesical procedures (cystolithotripsy, cystolithopaxy or manual
ragmentation) [4,5,18].
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[34
ne must evaluate preoperatively the exact size and location of the
tone burden, determine the point at which the stent is stuck and
hen manage it accordingly to minimize the number of therapeutic
essions and so the morbidity of additional procedures. However,
herapeutic strategy is also determined by the availability of technol-
gy. In this series lower coil encrustations were managed by forceps
ragmentation before the availability of endovesical lithotripsy. Sim-
larly, for upper coil encrustations open pyelolithotomy was used
hen PCNL was not yet available.
lthough encrusted stents can be managed successfully in the major-
ty of cases, the best treatment is prevention. Patients must be
ounselled as to when their stent should be changed, and must be
racked very closely. It is advisable to maintain a record of all stents
nserted and to keep track of their date of removal. Some authors
ave proposed the use of a computer tracking program to ensure
hat stents are removed or changed in a timely fashion. Ather et al.
eported a significantly lower incidence of overdue ureteral stents
from 12.5% to 1.2% during a 1-year period) by the use of a computer
rogram [26].
onclusion
tent encrustation constitutes one of the most difficult complications
f ureteral stents. Its management is a complex clinical scenario for
he treating surgeon. Accurately determining the location and the
egree of encrustation is an important part of preoperative plan-
ing. Most encrusted and retained ureteral stents can be removed
sing endoscopic techniques. This minimally invasive approach is
ecommended as first-line therapy. Open surgery is an option if
ndourology fails or in the presence of a large stone burden. How-
ver, the best treatment is the prevention of this complication by
roviding detailed patient education and developing a computerized
racking system.
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